○Tetsuya Ikeda¹, Ryo Okumura¹, Jun Kato¹ (1. Grad Sch Health Sci, Kyoto Tachibana Univ, Kyoto, Japan)

○Mohammad Moniruzzaman¹, Yusuke Fujioka ¹, Akihide Takeuchi ², Akio Masuda ³, Masahiro Neya ⁴, Shinsuke Ishigaki ¹ (1. Molecular Neuroscience Research Center, Shiga University of Medical Science , 2. Dept of Developmental Biol and Func Genomics, Ehime Univ Grad Sch of Med, Japan , 3. Center for Neurological Dis and Cancer, Nagoya Univ Grad Sch of Med, Japan , 4. KNC Laboratories Co., Ltd., Japan )

○Toshihide Takeuchi^1,3, Kazuhiro Maeta³, Xin Ding^2,3, Yukako Oe³, Akiko Takeda^2,3, Mana Inoue², Seiichi Nagano³, Tsuyoshi Fujihara⁴, Seiji Matsuda⁴, Shinsuke Ishigaki⁵, Kentaro Sahashi⁵, Eiko Minakawa⁶, Hideki Mochizuki³, Masahiro Neya⁴, Gen Sobue⁵, Yoshitaka Nagai^1,2,3 (1. LSRI, Kindai University, 2. Kindai University Faculty of Medicine, 3. Osaka University Graduate School of Medicine, 4. KNC Laboratories Co., Ltd., 5. Nagoya University Graduate School of Medicine, 6. NCNP)

○Hiroaki Adachi¹, Zhe Huang¹, Tomoko Toyota¹, Masahisa Katsuno², Gen Sobue³ (1. Department of Neurology, University of Occupational and Environmental Health, Japan, 2. Nagoya University Graduate School of Medicine, 3. Graduate School of Medicine, Aichi Medical University )

○Shizuka Ishitani¹, Tohru Ishitani¹ (1. RIMD, Osaka University, Osaka, Japan)

○Yui Tada¹, Kodai Kume¹, Kosuke Hosoba², Tatsuo Miyamoto³, Yuishin Izumi⁴, Hideshi Kawakami¹ (1. Research Institute for Radiation Biology and Medicine, Hiroshima University, 2. raduate School of Integrated Sciences for Life, Hiroshima University, 3. Graduate School of Medicine, Yamaguchi University, 4. Graduate School of Biomedical Sciences, Tokushima University)

○Tomoki Sekimori¹, Ichiro Kawahata¹, Takuya Sasaki^1,2, Kohji Fukunaga^1,3 (1. Dept Pharmacol, Grad Sch Pharm, Tohoku Univ, Miyagi, Japan, 2. Dept Neuropharmacol, Grad Sch Med, Tohoku Univ, Miyagi, Japan, 3. BRI Pharma Inc., Miyagi, Japan)